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LETTERS TO THE EDITORMacromolecule lymph-compatible MR contrast agent
for the diagnosis of lymphatic circulation disorders
Imaging can be important for diagnosis of lymphatic disor-
ders. However, visualizing the lymphatic system remains diffi-
cult. Conventional radionuclide-based lymphoscintigraphy
(LSG) imaging has poor resolution. Magnetic resonance image
(MRI) in combination with LSG can provide a more complete
evaluation of the lymphatic system,1 but the slow lymphatic flow
can be visualized with conventional noncontrast MRI only
when lymph flow is impaired or the lymphatic vessels are dilated
and filled with stagnated lymph.2 Although in MR imaging
lymph flow itself may act as a contrast medium to highlight the
path of the lymphatic channels when the background is satu-
rated, we believe a positive contrast agent is optimal to assess
lymphatic function.
The lymphatic system absorbs and transports macromolecule
fatty acids and fats as chyle from tissue space to the circulatory
system. The aim of injection of contrast agent into the intradermis
is to facilitate initial diffusion into the initial lymph vessels or
precollectors. Subsequently, the contrast agent travels through
lymph collector, deep lymph vessels, regional lymph nodes, and
finally into the circulation.
At present, magnetic resonance lymphangiography (MRL)
using commercially available Gd-containing contrast agent can
reflect the anatomy and functional status of lymphatic vessels and
lymph nodes.3 However, the quality of images and the assessment
of lymph transport function are affected by the low molecular
weight contrast agent delivered directly into the lymphatic system
and the absorption of the agent from the tissues surrounding the
site of injection.4
The enhancement rate of lymph nodes is closely associated
with the molecular size of the contrast agent used in MRL after
subcutaneous administration. Small molecular contrast agents are
only temporarily retained in lymph nodes. This results in only
short-term enhancement of lymph nodes. Therefore, a macromol-
ecule, lymph-compatible MR contrast agent could be useful in
imaging of the lymphatic system. Such an agent likely could be
more specifically delivered into the lymphatic system and retained
for longer periods of time in lymph nodes, which may improve the
outcome of MRL.
In conclusion, contrast-enhanced MRL with commercially
available low molecular weight contrast agents has significant
limitations in clinical practice. The development of a macromole-
cule lymph-compatible contrast agent for contrast-enhancedMRL
would reduce the image artifact of veins and improve the diagnosis
of lymphatic circulation disorders in the clinical practice.
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Regarding “Predicted shortage of vascular surgeons
in the United States: Population and workload
analysis”
We applaud Satiani et al1 for addressing the impending short-
age of vascular surgeons in the United States. Attitudes of medical
students and trainees are changing. This has at times been ascribed
as a gender issue. Lifestyle and time for family is important to men
and women in training and clearly has an effect on their career
choice and type of practice. Although Newton et al2 reported the
proportion of women choosing a specialty with a controllable
lifestyle increased from 18% in 1996 to 36% in 2003, the propor-
tion of men choosing a controllable lifestyle increased from 28% in
1996 to 45% in 2003. In his Presidential address to the Eastern
Vascular Surgery Society, Dr Perler surmised that “controllable
lifestyle is more of an issue for men than for women.”3 We believe
in 2009 that a controllable lifestyle is an equally important issue to
men and women.
For several years now, women have comprised roughly 50% or
more of graduating medical student classes, yet a mere 13.7%make
up our current class of 2-year vascular surgery fellows. Although
improvement has been seen with our integrated vascular residents,
where 22% of residents are women, we still rank far below national
standards. Conclusions quoted by Satiani et al1 fromMcMurray et
al4 that the shortage of physicians is due to part-time work by
women may be true in the United Kingdom but has not been
demonstrated in the United States, let alone in vascular surgery.
Men and women in vascular surgery continue to strive for an
optimal blend of career and family. And why shouldn’t we? One
would hope that we learn from the past how we can shape the
future.Wearing the badge of dangerously long hours and going for
days without seeing family is no longer tolerable or admirable by
today’s surgeons or patients. Trusting one’s partners to form a
cohesive team approach to vascular surgery is not gender-based.
The last statement by Satiani et al, “Persuading more medical
students to choose Vascular Surgery, incentives to work in rural
areas, job sharing, and encouraging less than full time equivalent
Vascular Surgeons to continue to work longer or transition into
office-practices must all be among innovative approaches to solv-
ing the shortage predicament ahead,” goes a considerable distance
in detailing what we can do as a society to bring improved care to
each other and our patients.
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anatomically high-risk patients: Safe and durable
except for radiation-induced stenosis”
Shin et al1 described the technical feasibility and durability of
CAS in supposed medically (MED; 132 patients) or anatomically
(ANAT; 98 patients) high-risk patients using Sapphire criteria.2
Innocent readers might hail CAS as the treatment of choice in the
majority of these “high risk” patients.
The ANAT cohort (overall 30 day stroke/death rate 3%)
comprised 16 (6%) patients with previous neck radiation, who
showed an increased rate (22.2%) of restenosis. Surprisingly, the
preprocedural cerebral status of these 16 patients was not reported
separately, but less than one-third of the ANAT cohort had been
symptomatic prior to carotid artery stenting (CAS). As in Sap-
phire,2,3 “high risk for surgery” should not bemixed up with “high
risk for stroke.” Although a patient with asymptomatic 70%
stenosis with previous radiation might be considered anatomically
high risk, this patient is certainly not at high risk for stroke and
should therefore not be offered high-risk (endovascular) carotid
revascularization. The very same accounts for patients with asymp-
tomatic restenosis following prior carotid endarterectomy (CEA),
who comprised 70% of the ANAT cohort. At the level of periop-
erative risk as reported in Sapphire, all potential benefit from any
intervention ceases, and neither surgery nor angioplasty can ever
prevent long-term stroke in these asymptomatic patients.
Treating asymptomatic patients by CAS because of clinical
factors that make them high risk for other events than stroke will
do little to reduce the overall risk of stroke in the general popula-
tion. Clinicians that uncritically implement CAS justified on Sap-
phire outcomes will not do their patients any service.
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Reply
I deplore the loss of the Age of Innocence. It is obvious to any
“innocent” or open-minded reader that the purpose of this manu-
script is not to endorse liberal use of carotid artery stenting (CAS)
in asymptomatic patients, but simply to present our experience
with patients with hostile neck undergoing CAS, and, in particular,
in patients with radiation-induced stenosis. Contrary to the quoted
3% combined 30-day stroke/death rate, the actual rate in our
anatomically high-risk cohort was 2%, which highlights that CAS
can be performed safely in patients with hostile neck. In fact, this
early outcome is within the recommended threshold of 3% com-
bined stroke/death rate for carotid endarterectomy for asymptom-
atic carotid stenosis. To further correct the above letter, we do not
